Literature DB >> 17075351

Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease.

F Magro, C Costa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17075351     DOI： 10.1097/01.mib.0000232468.15950.34

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  5 in total

1.  IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.

Authors:  Victoria Langer; Eugenia Vivi; Daniela Regensburger; Thomas H Winkler; Maximilian J Waldner; Timo Rath; Benjamin Schmid; Lisa Skottke; Somin Lee; Noo Li Jeon; Thomas Wohlfahrt; Viktoria Kramer; Philipp Tripal; Michael Schumann; Stephan Kersting; Claudia Handtrack; Carol I Geppert; Karina Suchowski; Ralf H Adams; Christoph Becker; Andreas Ramming; Elisabeth Naschberger; Nathalie Britzen-Laurent; Michael Stürzl
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

2.  Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.

Authors:  Cédric Louvet; Gregory L Szot; Jiena Lang; Michael R Lee; Nicolas Martinier; Gideon Bollag; Shirley Zhu; Arthur Weiss; Jeffrey A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

3.  Nilotinib-mediated mucosal healing in a rat model of colitis.

Authors:  Pinar Ataca; Mujde Soyturk; Meral Karaman; Mehtat Unlu; Ozgul Sagol; Gozde Dervis Hakim; Osman Yilmaz
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

Authors:  Gozde Dervis Hakim; Mujde Soyturk; Mehtat Unlu; Pinar Ataca; Meral Karaman; Ozgul Sagol; Elif Borekci; Osman Yilmaz
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

5.  Imatinib might constitute a treatment option for lung involvement in COVID-19.

Authors:  David Bernal-Bello; Beatriz Jaenes-Barrios; Alejandro Morales-Ortega; José Manuel Ruiz-Giardin; Virginia García-Bermúdez; Begoña Frutos-Pérez; Ana Isabel Farfán-Sedano; Cristina de Ancos-Aracil; Fernando Bermejo; Mario García-Gil; Antonio Zapatero-Gaviria; Juan Víctor San Martín-López
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.